NASDAQ:BNR Burning Rock Biotech Q3 2026 Earnings Date & Estimates $13.27 -0.05 (-0.38%) Closing price 11/20/2026 03:58 PM EasternExtended Trading$13.28 +0.02 (+0.11%) As of 11/20/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Burning Rock Biotech is estimated to report Q3 2026 earnings on Monday, November 23, 2026. The conference call is scheduled for November 27, 2026 at 12:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 23, 2026Conference Call DateNovember 27, 2026Conference Call12:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Burning Rock Biotech in Q3 2026Burning Rock Biotech is expected to post earnings of -$0.3412 per share on revenue of $19.20 million. Burning Rock Biotech last reported on September 10, 2026, posting -$0.20 per share and beating the -$2.2883 consensus estimate.Consensus EstimatesConsensus EPS-$0.3412Expected Revenue$19.20 millionRecent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.20 (Beat by +$2.0883)Last Quarter Revenue$19.84 millionPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Burning Rock Biotech Q3 2026 Earnings FAQ When does Burning Rock Biotech report Q3 2026 earnings? Burning Rock Biotech (NASDAQ:BNR) is estimated to report Q3 2026 earnings on Monday, November 23, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Burning Rock Biotech's Q3 2026 earnings call? Burning Rock Biotech's Q3 2026 earnings conference call is scheduled for Friday, November 27, 2026 at 12:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Burning Rock Biotech? Analysts expect Burning Rock Biotech to post earnings of -$0.3412 per share for Q3 2026. How much revenue is Burning Rock Biotech expected to report? The consensus revenue estimate for Burning Rock Biotech is $19.20 million for Q3 2026. Burning Rock Biotech Earnings HeadlinesBurning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026November 17, 2026 | globenewswire.comBurning Rock Biotech (BNR) versus Its Competitors Critical AnalysisNovember 17, 2026 | americanbankingnews.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. | Profits Run (Ad)Burning Rock Biotech (BNR) Projected to Release Earnings on TuesdayNovember 16, 2026 | americanbankingnews.comBurning Rock Biotech Ltd (BNR) Shares Surge 3.3% -- What GF Score of 53 Tells InvestorsSeptember 25, 2026 | gurufocus.comBurning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts GrowthSeptember 10, 2026 | rttnews.comSee More Burning Rock Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Burning Rock Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Burning Rock Biotech and other key companies, straight to your email. Email Address About Burning Rock BiotechBurning Rock Biotech (NASDAQ:BNR) is a precision oncology company that develops and provides next-generation sequencing tests for cancer. Its testing uses tissue and blood samples to help inform treatment decisions, monitor disease and support cancer research. The company also provides research and clinical-trial services to pharmaceutical companies, including support for the development of cancer therapies and diagnostic tests. Burning Rock is headquartered in Guangzhou, China, and its business primarily serves the Chinese healthcare and life sciences markets. Founded in 2014, Burning Rock focuses on applying genomic testing to cancer care, including the development of tests for treatment selection and disease monitoring.View Burning Rock Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/16 - 11/20If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in LimboAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestOwens Corning's Stock Slump May Have a Silver Lining for Dividend InvestorsThe Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity StocksHard Drives Were Left for Dead, But Seagate and Western Digital Are Soaring Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.